Top Stories
Hindalco Industries Q4 Results: EBITDA crosses ₹10,000 crore; revenue jumps 20% YoY RBI to transfer record Rs 2.87 lakh crore dividend to government for FY26; balance sheet expands 20.61% Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% Info Edge Q4 results: Revenue up 17%, operating margins improve 639 bps YoY Supreme Court to hear PIL against CBSE’s compulsory third language rule for Class 9 students next week MTAR Technologies market cap surges ₹1,019 crore as ₹467 crore international order drives stock to 52-week high Capital Group buys ₹20,000 crore of Adani stocks while selling Reliance – the biggest FII pivot of 2026 Central Bank of India shares in focus today as Government launches OFS to sell 4% stake Hindalco Industries Q4 Results: EBITDA crosses ₹10,000 crore; revenue jumps 20% YoY RBI to transfer record Rs 2.87 lakh crore dividend to government for FY26; balance sheet expands 20.61% Sun Pharma Q4 Results: Net profit rises 26.2% YoY, EBITDA grows over 6% Info Edge Q4 results: Revenue up 17%, operating margins improve 639 bps YoY Supreme Court to hear PIL against CBSE’s compulsory third language rule for Class 9 students next week MTAR Technologies market cap surges ₹1,019 crore as ₹467 crore international order drives stock to 52-week high Capital Group buys ₹20,000 crore of Adani stocks while selling Reliance – the biggest FII pivot of 2026 Central Bank of India shares in focus today as Government launches OFS to sell 4% stake
TAG

# Durvalumab